Development, optimization and characterization of glycyrrhetinic acid–chitosan nanoparticles of atorvastatin for liver targeting

References

• Brannon-Peppas L, Blanchette JO. (2012). Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 64:206–12
   Web of Science ®Google Scholar
• Calderon RM, Cubeddu LX, Goldberg RB, Schiff ER. (2010). Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. Mayo Clin Proc 2010;85:349–56
   PubMed Web of Science ®Google Scholar
• Calvo P, Remunan-Lopez C, Vila-Jato J, Alonso M. (1997). Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63:125–32
   Web of Science ®Google Scholar
• Chaudhary S, Garg T, Murthy RS, et al. (2014). Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Gagandeep G, Garg T, Malik B, et al. (2014). Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci 53:10–16
   PubMed Web of Science ®Google Scholar
• Garg T, Goyal AK. (2014). Biomaterial-based scaffolds – current status and future directions. Expert Opin Drug Deliv 11:767–89
   PubMed Web of Science ®Google Scholar
• Garg T, Kumar A, Rath G, Goyal AK. (2014a). Gastroretentive drug delivery systems for therapeutic management of peptic ulcer. Crit Rev Ther Drug Carrier Syst 31:531–57
   PubMed Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. (2014b). Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis. Crit Rev Ther Drug Carrier Syst 31:331–64
   PubMed Web of Science ®Google Scholar
• Garg T, Singh O, Arora S, Murthy R. (2012). Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 29:1–63
   PubMed Web of Science ®Google Scholar
• Goyal G, Garg T, Malik B, et al. (2013). Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Goyal G, Garg T, Rath G, Goyal AK. (2014a). Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease. Crit Rev Ther Drug Carrier Syst 31:89–119
   PubMed Web of Science ®Google Scholar
• Goyal G, Garg T, Rath G, Goyal AK. (2014b). Current nanotechnological strategies for treating glaucoma. Crit Rev Ther Drug Carrier Syst 31:365–405
   PubMed Web of Science ®Google Scholar
• Hu L, Song W, Zhang H, Gu D. (2013). HPLC-UV method development for atorvastatin calcium micro-emulsion determination in rat plasma and its application to elucidate pharmacokinetic behavior after oral administration to rats. Metabolism 2:3839–44
   Google Scholar
• Janes K, Alonso M. (2003). Depolymerized chitosan nanoparticles for protein delivery: preparation and characterization. J Appl Polymer Sci 88:2769–76
   Web of Science ®Google Scholar
• Johal HS, Garg T, Rath G, Goyal AK. (2014). Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Joshi D, Garg T, Goyal AK, Rath G. (2014). Advanced drug delivery approaches against periodontitis. Drug Deliv. [Epub ahead of print]
   Web of Science ®Google Scholar
• Kataria K, Sharma A, Garg T, et al. (2014). Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett 4:79–86
   Google Scholar
• Kateb B, Chiu K, Black KL, et al. (2011). Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage 54:S106–24
   PubMed Web of Science ®Google Scholar
• Kaur M, Garg T, Rath G, Goyal AK. (2014a). Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst 31:49–88
   PubMed Web of Science ®Google Scholar
• Kaur M, Malik B, Garg T, et al. (2014b). Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Kaur N, Garg T, Goyal AK, Rath G. (2014c). Formulation, optimization and evaluation of curcumin-beta-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy. Drug Deliv. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Kaur P, Garg T, Rath G, et al. (2014d). Surfactant-based drug delivery systems for treating drug-resistant lung cancer. Drug Deliv. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Kaur R, Garg T, Das Gupta U, et al. (2014e). Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. [Epub ahead of print]
   Web of Science ®Google Scholar
• Kaur R, Garg T, Malik B, et al. (2014f). Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Deliv. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Kaur R, Garg T, Rath G, Goyal AK. (2014g). Advanced aerosol delivery devices for potential cure of acute and chronic diseases. Crit Rev Ther Drug Carrier Syst 31:495–530
   PubMed Web of Science ®Google Scholar
• Kondratenko R, Mustafina S, Baltina L, et al. (2001). Synthesis and antiulcer activity of 3-O-acylated glycyrrhetic acid methylates. Pharm Chem J 35:243–6
   Google Scholar
• Lin A, Liu Y, Huang Y, et al. (2008). Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Int J Pharm 359:247–53
   PubMed Web of Science ®Google Scholar
• Malik R, Garg T, Goyal AK, Rath G. (2014). Polymeric nanofibers: targeted gastro-retentive drug delivery systems. J Drug Target. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Mao S-J, Hou S-X, He R, et al. (2005). Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes. World J Gastroenterol 11:3075
   PubMed Web of Science ®Google Scholar
• Marwah H, Garg T, Goyal AK, Rath G. (2014). Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Modgill V, Garg T, Goyal AK, Rath G. (2014). Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif Cells Nanomed Biotechnol. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Morie A, Garg T, Goyal AK, Rath G. (2014). Nanofibers as novel drug carrier – an overview. Artif Cells Nanomed Biotechnol. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Nabavi SM, Nabavi SF, Eslami S, Moghaddam AH. (2012). In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue. Food Chem 132:931–5
   Web of Science ®Google Scholar
• Negishi M, Irie A, Nagata N, Ichikawa A. (1991). Specific binding of glycyrrhetinic acid to the rat liver membrane. Biochim Biophys Acta 1066:77–82
   PubMed Web of Science ®Google Scholar
• Rohilla R, Garg T, Goyal AK, Rath G. (2014). Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Deliv. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Saltiel C, Chen Q, Manickavasagam S, et al. (2004). Identification of the dispersion behavior of surface treated nanoscale powders. J Nanopart Res 6:35–46
   Web of Science ®Google Scholar
• Sayın B, Somavarapu S, Li X, et al. (2008). Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Int J Pharm 363:139–48
   PubMed Web of Science ®Google Scholar
• Sharma A, Garg T, Aman A, et al. (2014a). Nanogel-an advanced drug delivery tool: Current and future. Artif Cells Nanomed Biotechnol. [Epub ahead of print]
   Web of Science ®Google Scholar
• Sharma R, Singh H, Joshi M, et al. (2014b). Recent advances in polymeric electrospun nanofibers for drug delivery. Crit Rev Ther Drug Carrier Syst 31:187–217
   PubMed Web of Science ®Google Scholar
• Singh B, Garg T, Goyal AK, Rath G. (2014a). Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol. [Epub ahead of print]
   Web of Science ®Google Scholar
• Singh H, Sharma R, Joshi M, et al. (2014b). Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol. [Epub ahead of print]
   Web of Science ®Google Scholar
• Tian Q, Wang W, He X, et al. (2009). Glycyrrhetinic acid-modified nanoparticles for drug delivery: preparation and characterization. Chin Sci Bull 54:3121–6
   Web of Science ®Google Scholar
• Valan M, Britto A, Venkataraman R. (2010). Phytoconstituents with hepatoprotective activity. Int J Chem Sci 8:1421–32
   Google Scholar